financetom
Business
financetom
/
Business
/
US renewable fuel credits rally to multi-month highs despite Trump reelection
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US renewable fuel credits rally to multi-month highs despite Trump reelection
Nov 9, 2024 1:35 PM

NEW YORK (Reuters) - U.S. renewable fuel credits rose to multi-month highs on Friday on increased demand from refiners trying to comply with mandates and higher prices for soyoil, surprising traders who expected Donald Trump's reelection as U.S. president to weigh on the market.

Rising prices for the credits, also called Renewable Identification Numbers (RINs), are welcome news for biofuel producers who depend on them to make up for high output costs. However, they also worsen the pain for petroleum refiners whose profit margins have slumped sharply this year due to oversupply and weak demand.

Prices for both the D4 RINs, issued to biomass-based diesel producers, and the D6 RINs, issued to ethanol suppliers, rose as high as 79 cents each on Friday, traders said.

Those are the highest levels since January, according to LSEG data.

The U.S. government mandates mixing of low-carbon fuels in the country's transportation fuel mix, and issues RINs to companies supplying them. Refiners who do not meet their targets can buy RINs from others or risk fines.

Trump's victory in this week's U.S. elections had led to speculation that small refineries will find it easier to get exemptions to their RIN generation targets under his administration, OPIS analyst Tom Kloza said.

However, Trump has not yet outlined any plans to do that.

"There's uncertainty around whether Trump will reintroduce widespread small refinery exemptions, so some small refiners may be buying now to avoid being caught short," said Alex Hodes, analyst at energy brokerage StoneX.

Market participants also expect fewer RINs to be available for trade next year, partly due to tighter government mandates and weak fuel demand reducing renewables blending, said Will Faulkner, founder of industry analysis firm Carbon Acumen.

Meanwhile, soybean oil prices have also rallied this week on expectations that Trump could impose tariffs on imports of biofuel feedstocks.

Higher prices for feedstocks erode producer margins, making them price their RINs higher, said Paul Niznik, director of energy at consultancy firm Capstone.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Nov 12, 2025
Overview * LightInTheBox ( LITB ) Q3 net income rises to $2.8 mln from $0.3 mln last year * Company Q3 revenue declines 3% yr/yr, reflecting focus on margin preservation * Gross margin improves to 66.9% from 61.1% last year, driven by high-margin products Outlook * LightInTheBox ( LITB ) expects overall revenue growth in 2026 * Company plans broader...
Coya Therapeutics' Q3 net loss narrows
Coya Therapeutics' Q3 net loss narrows
Nov 12, 2025
Overview * Coya Therapeutics ( COYA ) Q3 net loss narrows to $2.1 mln from $4.0 mln last year * Company reports $3.6 mln collaboration revenue due to IND approval milestone * Coya completes $23 mln public offering, extending cash runway into 2H 2027 Outlook * Company expects to receive $4.2 mln milestone payment upon first patient dosing in ALS...
Cypherpunk Technologies' Q3 net loss narrows
Cypherpunk Technologies' Q3 net loss narrows
Nov 12, 2025
Overview * Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year * Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy * Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy Outlook * Company did not provide specific financial guidance for future quarters or year Result...
Corbus Pharma Q3 net loss widens to $23.3 mln
Corbus Pharma Q3 net loss widens to $23.3 mln
Nov 12, 2025
Overview * Corbus Pharmaceuticals ( CRBP ) Q3 net loss widens to $23.3 mln, driven by clinical development costs * Company completed $75 mln public offering, extending cash runway into 2028 * CRB-701 clinical data shows promising ORR in HNSCC, cervical, and bladder cancers Outlook * Company plans to meet FDA in Q1 2026 for CRB-701 data review * Corbus...
Copyright 2023-2025 - www.financetom.com All Rights Reserved